Laboratory News and Research

RSS

New AI software can create proteins that may be useful as vaccines, cancer treatments

Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

21 Jul 2022

A different approach to build a more durable, broadly effective COVID-19 vaccine

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

21 Jul 2022

Cancer cells produce small amount of collagen that impacts tumor microbiome and immunity

Cancer cells produce small amounts of their own form of collagen, creating a unique extracellular matrix that affects the tumor microbiome and protects against immune responses, according to a new study by researchers at The University of Texas MD Anderson Cancer Center.

21 Jul 2022

Associations between whole blood viscosity and SARS-CoV-2-linked death

Researchers depicted the link between COVID-19-associated mortality and whole blood viscosity (WBV).

21 Jul 2022

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

The Focused Ultrasound Foundation and the Children's Tumor Foundation (CTF) have established a partnership to advance innovative, noninvasive treatments in pediatrics.

21 Jul 2022

Kessler Foundation researchers receive NJHF grants to advance research in neurological disabilities

Each year, New Jersey Health Foundation (NJHF) accepts applications for grants for research projects that demonstrate exciting potential to help scientists leverage their preliminary findings to qualify for additional funding to advance their research. This year, grants were awarded to three researchers at Kessler Foundation.

21 Jul 2022

Antibiotics have sex-specific effects on the gut microbiome, preclinical study finds

In a new study, researchers at Cedars-Sinai found that antibiotics have sex-specific effects on the gut microbiome makeup of male and female laboratory rats. The findings, published in the journal Frontiers in Microbiology, could have implications for using the drugs in humans to treat or prevent bacterial infection.

20 Jul 2022

How the Omicron variant shifted the biology of SARS-CoV-2

Researchers discuss significant antigenic changes within the spike protein of new SARS-CoV-2 VOCs like the Omicron variant.

20 Jul 2022

Scientists find a promising new combination therapy for certain types of lung tumors

Scientists at the Francis Crick Institute have found that using immunotherapy alongside a drug that blocks a common gene mutation in lung cancer could be a promising new combination therapy for certain types of lung tumors.

20 Jul 2022

Study finds significant evidence for inaccurate and misleading labeling of CBD content

In a new study, Johns Hopkins Medicine researchers tested more than 100 topical cannabidiol (CBD) products available online and at retail stores, and found significant evidence of inaccurate and misleading labeling of CBD content.

20 Jul 2022

Ghana announces first-ever Marburg virus outbreak

Ghana announced the country’s first Marburg virus disease outbreak, after receiving a confirmatory report of the disease from the World Health Organization’s (WHO) Collaborating Centre Laboratory.

20 Jul 2022

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Yale scientists have developed a novel Omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines.

20 Jul 2022

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine.

20 Jul 2022

New vaccine shows promise to fight Lassa virus

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever.

19 Jul 2022

CDC experts update on monkeypox in the United States

Scientists working with the CDC provide the latest information about monkeypox in the U.S.

19 Jul 2022

Discovery about how a certain protein is activated in tumor cells could lead to better treatments

Better treatments for some of cancer's deadliest forms could be closer due to a University of California, Irvine-led discovery about how a certain protein is activated in tumor cells.

19 Jul 2022

First-of-its-kind roadmap reveals how stem cells become sensory interneurons

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a first-of-its-kind roadmap detailing how stem cells become sensory interneurons -; the cells that enable sensations like touch, pain and itch.

19 Jul 2022

Study shows how a critical Lassa virus protein drives infection

Lassa fever is a viral illness that is far too common in West Africa. Although it can have a mortality rate of 15 percent in severe cases, up to 90% in pregnant women, and causes deafness in a quarter of survivors, there is no vaccine or antiviral to protect against Lassa virus.

19 Jul 2022

Influence of chr12q24.13 domain on COVID-19 severity

Researchers evaluated the probable impact of the chr12q24.13 domain on the outcomes of laboratory-validated SARS-CoV-2 infection.

19 Jul 2022

Could Vitamin B6 Reduce Anxiety and Depression?

In this interview, we speak to Dr. David Field about his latest research into anxiety and depression and whether vitamin B6 supplements could help to reduce it.

19 Jul 2022

Laboratory News and Research

New AI software can create proteins that may be useful as vaccines, cancer treatments

A different approach to build a more durable, broadly effective COVID-19 vaccine

Cancer cells produce small amount of collagen that impacts tumor microbiome and immunity

Associations between whole blood viscosity and SARS-CoV-2-linked death

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

Kessler Foundation researchers receive NJHF grants to advance research in neurological disabilities

Antibiotics have sex-specific effects on the gut microbiome, preclinical study finds

How the Omicron variant shifted the biology of SARS-CoV-2

Scientists find a promising new combination therapy for certain types of lung tumors

Study finds significant evidence for inaccurate and misleading labeling of CBD content

Ghana announces first-ever Marburg virus outbreak

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

New vaccine shows promise to fight Lassa virus

CDC experts update on monkeypox in the United States

Discovery about how a certain protein is activated in tumor cells could lead to better treatments

First-of-its-kind roadmap reveals how stem cells become sensory interneurons

Study shows how a critical Lassa virus protein drives infection

Influence of chr12q24.13 domain on COVID-19 severity

Could Vitamin B6 Reduce Anxiety and Depression?

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest Life Science News